Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
AIS SIGED International Conference on Information Systems Education and Research 2022 ; : 114-128, 2022.
Article in English | Scopus | ID: covidwho-2325537

ABSTRACT

This case study describes a usability testing course in which students learn by practicing several evaluation methods. The on-campus format makes it possible for teachers and students to meet to discuss recorded test sessions and students can observe other students' execution of pilot studies conducted on campus. The COVID-19 pandemic placed new demands on this course. In-person activities were avoided by some students and many test participants. Some student teams tried remote usability testing. Interestingly, screen recordings (with sound) of the test sessions show that remote testing sometimes helped the students focus more on observation and less on (inappropriately) guiding the test subjects. Another effect was that the students found it easier to recruit participants than during the previous years when the university was teeming with students, lecturers, and non-academic staff. However, the recruited participants were often notably limited to the students' circles of friends. © (2022) by Association for Information Systems (AIS) All rights reserved.

2.
Cytokine ; 146: 155589, 2021 10.
Article in English | MEDLINE | ID: covidwho-1240276

ABSTRACT

BACKGROUND: Acute kidney injury is common in COVID-19 patients admitted to the ICU. Urinary biomarkers are a non-invasive way of assaying renal damage, and so far, urinary cytokines are not fully investigated. The current study aimed to assess urinary cytokine levels in COVID-19 patients. METHODS: Urine was collected from COVID-19 patients (n = 29) in intensive care and compared to a preoperative group of patients (n = 9) with no critical illness. 92 urinary cytokines were analyzed in multiplex using the Olink Target 96 inflammation panel and compared to clinical characteristics, and urinary markers of kidney injury. RESULTS: There were strong correlations between proinflammatory cytokines and between urinary cytokines and urinary kidney injury markers in 29 COVID-19 patients. Several cytokines were correlated to kidney injury, 31 cytokines to AKI stage and 19 cytokines correlated to maximal creatinine. CONCLUSIONS: Urinary inflammatory cytokines from a wide range of immune cell lineages were significantly upregulated during COVID-19 and the upregulation correlated with acute kidney injury as well as urinary markers of kidney tissue damage.


Subject(s)
Acute Kidney Injury/urine , Biomarkers/urine , COVID-19/urine , Critical Illness , Cytokines/urine , Aged , Albuminuria/urine , COVID-19/diagnosis , COVID-19/virology , Creatinine/blood , Creatinine/urine , Critical Care , Female , Humans , Male , Middle Aged , SARS-CoV-2/physiology
3.
J Crit Care ; 60: 249-252, 2020 12.
Article in English | MEDLINE | ID: covidwho-741329

ABSTRACT

PURPOSE: The aim of this study was to investigate potential markers of coagulopathy and the effects of thromboprophylaxis with low-molecular-weight heparin (LMWH) on thromboelastography (TEG) and anti-factor Xa in critically ill COVID-19 patients. MATERIAL AND METHODS: We conducted a prospective study in 31 consecutive adult intensive care unit (ICU) patients. TEG with and without heparinase and anti-factor Xa analysis were performed. Standard thromboprophylaxis was given with dalteparin (75-100 IU/kg subcutaneously). RESULTS: Five patients (16%) had symptomatic thromboembolic events. All patients had a maximum amplitude (MA) > 65 mm and 13 (42%) had MA > 72 mm at some point during ICU stay. Anti-factor Xa activity were below the target range in 23% of the patients and above target range in 46% of patients. There was no significant correlation between dalteparin dose and anti-factor Xa activity. CONCLUSIONS: Patients with COVID-19 have hypercoagulability with high MA on TEG. The effect of LMWH on thromboembolic disease, anti-factor Xa activity and TEG was variable and could not be reliably predicted. This indicates that standard prophylactic doses of LMWH may be insufficient. Monitoring coagulation and the LMWH effect is important in patients with COVID-19 but interpreting the results in relation to risk of thromboembolic disease poses difficulties.


Subject(s)
Anticoagulants/therapeutic use , COVID-19 Drug Treatment , Factor Xa Inhibitors/therapeutic use , Heparin, Low-Molecular-Weight/therapeutic use , Thrombelastography/methods , Adult , Blood Coagulation/drug effects , Blood Coagulation Disorders/complications , Blood Coagulation Disorders/drug therapy , Critical Illness , Dalteparin/adverse effects , Female , Humans , Intensive Care Units , Male , Middle Aged , Prospective Studies , Risk , Venous Thromboembolism/complications , Venous Thromboembolism/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL